Cefpodoxime Proxetil Alternative Names
Cefpodoxime proxetil is also known by its active metabolite name "cefpodoxime" and may be referred to as "cefpodoxime-proxetil" in some guidelines 1.
Key Nomenclature Points
The drug exists in two forms that are clinically relevant:
- Cefpodoxime proxetil: The prodrug form administered orally 2
- Cefpodoxime: The active metabolite that results after de-esterification in vivo 2, 3
Chemical and Structural Information
According to FDA labeling, the chemical name is (RS)-1(isopropoxycarbonyloxy) ethyl (+)-(6R, 7R)-7-[2-(2-amino-4-thiazolyl)-2-{(Z) methoxyimino} acetamido]-3-methoxymethyl-8-oxo-5-thia-1-azabicyclo [4.2.0]oct-2-ene-2-carboxylate with empirical formula C₂₁H₂₇N₅O₉S₂ 2.
Clinical Context
In medical literature and guidelines, the terms are often used interchangeably, though technically:
- Cefpodoxime proxetil refers to the oral formulation/prodrug
- Cefpodoxime refers to the active compound
Guidelines consistently refer to it as "cefpodoxime proxetil" when discussing oral administration 1, 4, while the active metabolite "cefpodoxime" is referenced when discussing antimicrobial activity and MIC values 1.
The drug is classified as a third-generation oral cephalosporin and is described as a structural analog of ceftriaxone 1.